Evidence map›Paper›PMID 40303565›Full record

ArticleJournal of applied statistics2025

A semiparametric accelerated failure time-based mixture cure tree.

Wisdom Aselisewine, Suvra Pal, Helton Saulo

Abstract read
In one paragraph

Article in Journal of applied statistics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Modeling Cure from Cancer Accounting for Inevitable Mortality.Journal of the Royal Statistical Society. Series C, Applied statistics · 2026
    Article
  3. Article
  4. Machine Learning Approach for Analyzing Mixed Case Interval Censored Data with a Cured Subgroup.Advances in statistical analysis : AStA : a journal of the German Statistical Society · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wisdom AselisewineDepartment of Mathematics, University of Texas at Arlington, Arlington, TX, USA.
Suvra PalDepartment of Mathematics, University of Texas at Arlington, Arlington, TX, USA.ORCID https://orcid.org/0000-0001-9864-9489
Helton SauloDepartment of Statistics, Universidade de Brasília, Brasília, Brazil.ORCID https://orcid.org/0000-0002-4467-8652

Funding

Using Machine Learning to Improve the Predictive Accuracy of Disease CureR15GM150091 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI PAL, SUVRA · 2023 to 2023
$452k
NIGMS NIH HHS R15 GM150091
6 · The paper itself

Abstract

The mixture cure rate model (MCM) is the most widely used model for the analysis of survival data with a cured subgroup. In this context, the most common strategy to model the cure probability is to assume a generalized linear model with a known link function, such as the logit link function. However, the logit model can only capture simple effects of covariates on the cure probability. In this article, we propose a new MCM where the cure probability is modeled using a decision tree-based classifier and the survival distribution of the uncured is modeled using an accelerated failure time structure. To estimate the model parameters, we develop an expectation maximization algorithm. Our simulation study shows that the proposed model performs better in capturing nonlinear classification boundaries when compared to the logit-based MCM and the spline-based MCM. This results in more accurate and precise estimates of the cured probabilities, which in-turn results in improved predictive accuracy of cure. We further show that capturing nonlinear classification boundary also improves the estimation results corresponding to the survival distribution of the uncured subjects. Finally, we apply our proposed model and the EM algorithm to analyze an existing bone marrow transplant data.

Indexed as

62N02cross-validationcure rateDecision treeEM algorithmmultiple imputation

Identifiers

PMID40303565
PMCPMC12035937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.